Hongqian Guo

Kingston Health Sciences Centre — Canada

Medicine · Health Sciences

49h-index9.0kcitations564works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(140), Bladder and Urothelial Cancer Treatments(127), Prostate Cancer Diagnosis and Treatment(124), Prostate Cancer Treatment and Research(115), Renal and related cancers(81)

Publications564 total

Radiographic Progression Without Prostate-specific Antigen Progression in Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Analysis of the ENZAMET Trial (ANZUP 1304)
European Urology Oncology·2026
Patient-derived organoids based on targeted biopsy of primary prostate cancer: development, identification, and drug screening
Annals of Medicine·2025Open Access
Supplementary Data from Cancer-Associated Fibroblast–Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance
2025Open Access
SLC6A19-mediated tryptophan uptake suppresses renal cell carcinoma metastasis via activating NAD+-dependent deacetylase SIRT1
Oncogenesis·2025· 1 citedOpen Access
TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1
Cellular Oncology·2025Open Access
The early therapeutic efficacy of robot-assisted laparoscopic radical prostatectomy with combined anterior and posterior approach: a cohort study
Scientific Reports·2025Open Access
Fully automated volumetric assessment of tumor burden using artificial intelligence on 68Ga-PSMA-11 PET predicts survival after 177Lu-PSMA therapy in metastatic Castration-resistant prostate cancer
European Journal of Nuclear Medicine and Molecular Imaging·2025· 1 cited
The expression of prostate-specific membrane antigen in intraductal carcinoma of the prostate
Scientific Reports·2025Open Access
WITHDRAWN: 2486P Quality of life analysis in patients with high-risk localized prostate cancer receiving neoadjuvant pamiparib plus abiraterone and ADT: A prospective study
Annals of Oncology·2025
2439P Two-year outcomes in very high-risk localized prostate cancer following neoadjuvant therapy with Poly(ADP-ribose) polymerase inhibitors and abiraterone: A pooled post-hoc analysis of two prospective trials
Annals of Oncology·2025
E3-Rewrite: Learning to Rewrite SQL for Executability, Equivalence,and Efficiency
arXiv (Cornell University)·2025Open Access
A randomized study of apalutamide in Chinese patients with non-metastatic castration-resistant prostate cancer
iScience·2025Open Access
Trend in testicular volume change after orchiopexy in 854 children with cryptorchidism
Asian Journal of Andrology·2025Open Access
9MW2821, a novel Nectin-4 antibody-drug conjugate (ADC), combined with toripalimab in treatment-naïve patients with locally advanced or metastatic urothelial carcinoma (la/mUC): Results from a phase 1b/2 study.
Journal of Clinical Oncology·2025· 4 cited
Final overall survival (OS) with talazoparib (TALA) + enzalutamide (ENZA) as an initial treatment in unselected patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the China cohort of the phase 3 TALAPRO-2 trial.
Journal of Clinical Oncology·2025
RETRACTED: Prognostic Impact of Surgical Intervention in Clear Cell Renal Cell Carcinoma: A SEER Database Analysis with Development and Validation of a Nomogram for Surgical Patients
2025Open Access
DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR SEPTIC SHOCK–ASSOCIATED ACUTE KIDNEY INJURY: A MULTICENTER STUDY USING NOMOGRAM MODELING
Shock·2025
Biomimetic Copper Nanozyme Reprograms Cold Tumor via Cuproptosis–Pyroptosis Crosstalk for Potent Renal Carcinoma Immunotherapy
ACS Applied Materials & Interfaces·2025· 7 cited
68Ga-pentixafor PET/CT predict the surgical outcome for the primary aldosteronism
Clinical and Translational Imaging·2025
IP23-32 IMPACT OF NEOADJUVANT HORMONAL THERAPY ON URINARY CONTINENCE RECOVERY AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY: A MULTICENTER PROPENSITY SCORE-MATCHED ANALYSIS
The Journal of Urology·2025
page 1 of 29Next →

Frequent Co-authors

Xiaozhi Zhao(20), Wenmin Cao(9), Junlong Zhuang(8), Tingsheng Lin(7), Yao Fu(6), Xuefeng Qiu(6), Qing Zhang(6), Ruimin Huang(5), Jun Yan(5), Changwei Ji(5), Chengwei Zhang(5), Giancarlo Marra(5), Huibo Lian(5), Qun Lu(4), Bo Jiang(4), Hong Luo(4), Xiaojing Huang(4), Mengxia Chen(4), Shiwei Zhang(4), Suhan Guo(4)